LRRC19 antibody (C-Term)
Quick Overview for LRRC19 antibody (C-Term) (ABIN500196)
Target
See all LRRC19 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- C-Term
-
Cross-Reactivity (Details)
- Species reactivity (tested):Human, mouse
-
Purification
- Peptide affinity chromatography
-
Immunogen
- LRRC19 antibody was raised against a 17 amino acid peptide near the carboxy terminus of human LRRC19.
-
Isotype
- IgG
-
-
-
-
Application Notes
-
ELISA. Western blot: 1 - 2 μg/mL.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. -
Restrictions
- For Research Use only
-
-
-
Concentration
- 1.0 mg/mL
-
Buffer
- PBS containing 0.02 % sodium azide
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Avoid repeated freezing and thawing.
-
Storage
- -20 °C
-
Storage Comment
- Store the antibody (in aliquots) at -20 °C.
-
-
- LRRC19 (Leucine Rich Repeat Containing 19 (LRRC19))
-
Alternative Name
- LRRC19
-
Background
- LRRC19 is a member of the extracellular leucine-rich repeat superfamily, a family of proteins that are thought to have diverse functions such as cell adhesion, signaling, and innate immunity. LRRC19 is closely related to the Toll-like receptors (TLRs), especially TLR3. LRRC19 does not contain a cytoplasmic Toll/IL-1 receptor (TIR) domain, but can activate NF-kB and induce the production of proinflammatory cytokines after stimulation with the TLR3 and other TLR ligands, suggesting that LRRC19 may play a role in the recognition and the response to certain pathogenic microorganisms. LRRC19 has also been suggested to be a potential biomarker for pancreatic tumor sensitivity to the anti-cancer, small molecule Src inhibitor AZD0530.Synonyms: Leucine-rich repeat-containing protein 19
-
Gene ID
- 64922
-
NCBI Accession
- NP_075052
-
UniProt
- Q9H756
Target
-